Michael Gale

机构：University of Minnesota, University of Minnesota, Duluth · ORCID：0000-0002-6332-7436

发表论文 556 篇 · 总被引 47827 次 · h-index 110

代表论文

• Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys (2023 · Journal of Medicinal Chemistry · 被引 63)
• Cellular RNA interacts with MAVS to promote antiviral signaling (2024 · Science · 被引 53)
• Innate immunity and interferon in SARS-CoV-2 infection outcome (2023 · Immunity · 被引 50)
• Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) (2023 · The Journal of Infectious Diseases · 被引 36)
• Correlates of HIV-1 control after combination immunotherapy (2025 · Nature · 被引 35)
• Increased interregional virus exchange and nucleotide diversity outline the expansion of chikungunya virus in Brazil (2023 · Nature Communications · 被引 33)